Literature DB >> 26551976

High Lung Cancer Incidence in Heavy Smokers Following Hospitalization due to Pneumonia.

Daniel Shepshelovich1, Hadar Goldvaser2, Yonatan Edel3, Tzippy Shochat4, Meir Lahav3.   

Abstract

INTRODUCTION: The rate of lung cancer incidence following pneumonia in heavy smokers is unknown. Heavy smokers hospitalized due to community-acquired pneumonia might be at high risk for subsequent lung cancer. The primary objective of this study was to determine lung cancer incidence in this high-risk population. PATIENTS AND METHODS: This was a single-center, retrospective cohort study that included heavy smokers hospitalized due to community-acquired pneumonia between January 1, 2007 and December 31, 2011 in Beilinson hospital, a large community hospital and tertiary center. Patients were identified by International Classification of Diseases, Ninth Revision coding from the hospital's registry. Two physicians reviewed every patient's medical file for patient demographics, smoking history, lung cancer risk factors, and anatomical location of pneumonia. Data were cross-checked with the database at the national cancer registry for new diagnoses of cancer.
RESULTS: There were 381 admissions for community-acquired pneumonia included in the final analysis. Thirty-one cases (8.14%; 95% confidence interval [CI], 5.9%-11.2%) of lung cancer were diagnosed during the first year after hospitalization. Lung cancer incidence was significantly higher in patients who had upper-lobe pneumonia (23.8%; 95% CI, 14.9%-40%). Lung cancer was located within the lobe involved by the pneumonia in 75.8% of patients.
CONCLUSIONS: A high lung cancer rate was found in heavy smokers admitted due to community-acquired pneumonia. The association was especially strong for patients with upper-lobe pneumonia. Screening with chest computed tomography should be strongly considered for these patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Pneumonia; Smoking

Mesh:

Year:  2015        PMID: 26551976     DOI: 10.1016/j.amjmed.2015.10.030

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  1 in total

1.  A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression.

Authors:  Rajib K Dutta; Srinivasan Chinnapaiyan; Lawrence Rasmussen; S Vamsee Raju; Hoshang J Unwalla
Journal:  Mol Ther       Date:  2018-12-06       Impact factor: 11.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.